Inventor · disambiguated record
Pascal Raymond Georges Poignard
Also filed as: POIGNARD PASCAL · POIGNARD PASCAL R G · POIGNARD PASCAL RAYMOND GEORGES
19 granted patents·4 pending applications·71 citations·filing 2010–2025
93Inventor score
Files withTHERACLONE SCIENCES INC12INT AIDS VACCINE INITIATIVE5INT AIDS VACCINE INITIATIVE INC2UNIV STRASBOURG2CHAN-HUI PO-YING1
Top patents by PatentIndex Score
23 records- 0196US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0296US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0395US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 0493USRE50268EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2022·Granted Jan 14, 2025·2 cites·30 claims
- 0593US10093720B2Broadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 9, 2018·12 cites·6 claims
- 0692US9051362B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityCHAN-HUI PO-YING·Filed 2010·Granted Jun 9, 2015·14 cites·20 claims
- 0791US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 0891US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 0987USRE49037EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Apr 19, 2022·3 cites·23 claims
- 1086US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 1185US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 1283US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 1381US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 1479US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 1578US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 1676US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 1769US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 1860US9920111B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2015·Granted Mar 20, 2018·0 cites·8 claims
- 1960US9382311B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Jul 5, 2016·0 cites·8 claims
- 2059US9796774B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Oct 24, 2017·0 cites·5 claims
- 2159US2025376504A1Bk virus neutralizing antibodiesUNIV STRASBOURG·Filed 2024·Application pending·0 cites
- 2259US2025376505A1Bk virus neutralizing antibodiesUNIV STRASBOURG·Filed 2024·Application pending·0 cites
- 2355US2024002446A1Proteoliposomes comprising a sars-cov-2 s glycoprotein ectodomain and their use as a vaccineUNIV GRENOBLE ALPES·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →